Products
Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Vitamin B12 test kit

(S)-AMG-510

Cat. No.: OB0225WX-1891
Appearance: Solid
Purity: ≥98%
Identity: Confirmed by NMR, HPLC, and LC-MS.
Size:
(<i>S</i>)-AMG-510
Add to basket

Product Overview

Description: (S)-AMG-510 is the S-isomer of sotorasib that functions as a selective KRAS G12C inhibitor through a covalent interaction with the mutant cysteine residue.
Synonym: Sotorasib; AMG-510; 2296729-00-3; AMG510; Lumakras; AMG-510 racemate; Kras G12C inhibitor 9; sotorasibum; Kras mutant-targeting AMG 510; 4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one; 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one; (1m)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(propan-2-yl)pyridin-3-yl)-4-((2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl)pyrido(2,3-d)pyrimidin-2(1H)-one; 6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-((2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl)pyrido(2,3-d)pyrimidin-2-one; (1R)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one; (1S)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one; Pyrido(2,3-d)pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(1-methylethyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl)-
CAS No.: 2252403-56-6
Compound CID: 137278711
Formula: C30H30F2N6O3
Formula Weight: 560.59

Specification

Relative Density: 1.36 g/cm3
Stability: 3 years in powder form.
Storage: Storage at -20°C.
Applications: (S)-AMG-510 is applied in advanced cancer research as a potent KRAS G12C inhibitor to study the selective targeting of mutant-driven signaling and the resulting induction of anti-tumor immunity.

Library Information

Target: Kras
Receptor: KRAS G12C; Ras
Pathways: MAPK
Plate Number: AOCL-25
Plate Location: c2
Empty Location: a1-h1; a12-h12
Container: 96-well plate
Formulation: 2mM DMSO
DMSO Max Solubility: 5.61 mg/mL; 10 mM
Inquiry
0
Inquiry Basket
Check Out

Copyright © Protheragen. All rights reserved.